Author:
Warwood Teresa L,Ohls Robin K,Wiedmeier Susan E,Lambert Diane K,Jones Cory,Scoffield Scott H,Neeraj Gupta,Veng-Pedersen Peter,Christensen Robert D
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,Pediatrics, Perinatology, and Child Health
Reference25 articles.
1. Egrie JC, Dwyer E, Lykos M, et al. Novel erythropoiesis stimulating protein (NESP) has a longer plasma half-life and greater in vivo biological activity than recombinant human erythropoietin. Blood 1997;99:56a.
2. Egrie JC, Browne JK . Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001;84 (Suppl.): 3–10.
3. Egrie JC, Dwyer E, Browne JK, et al. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Exp Hematol 2003;31:290–299.
4. www.aranesp.com .
5. Ohls RK, Dai A . The effect of Aranesp on the growth of fetal and neonatal erythroid progenitors. Blood 2003;102:18b.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献